0,915  0,002  Alcohol oxidase inhibitor
0,871  0,001  Alpha-N-acetylglucosaminidase inhibitor
0,846  0,004  Aldehyde oxidase inhibitor
0,765  0,002  Porphobilinogen synthase inhibitor
0,748  0,008  GST A substrate
0,721  0,002  GABA C receptor agonist
0,704  0,004  5 Hydroxytryptamine release inhibitor
0,697  0,004  Superoxide dismutase inhibitor
0,687  0,004  Ulceration
0,682  0,005  Histamine release inhibitor
0,670  0,010  Cholesterol antagonist
0,642  0,003  Acaricide
0,639  0,001  Aconitate hydratase inhibitor
0,641  0,004  FMO1 substrate
0,611  0,002  Ferrochelatase inhibitor
0,595  0,005  Peroxidase inhibitor
0,593  0,003  Succinate dehydrogenase inhibitor
0,589  0,002  Triose-phosphate isomerase inhibitor
0,579  0,010  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,573  0,011  GABA C receptor rho-3 antagonist
0,570  0,010  UGT1A6 substrate
0,560  0,003  5 Hydroxytryptamine uptake stimulant
0,573  0,017  Sensitization
0,558  0,002  Glutamate decarboxylase inhibitor
0,555  0,002  Excitatory amino acid transporter EAAC1 inhibitor
0,565  0,016  CTGF expression inhibitor
0,552  0,005  Antiseptic
0,556  0,015  UGT1A9 substrate
0,546  0,009  Antimutagenic
0,549  0,020  Antipruritic, allergic
0,551  0,022  Respiratory analeptic
0,542  0,015  Calcium channel L-type activator
0,515  0,002  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,523  0,017  Cardiovascular analeptic
0,519  0,014  Antipyretic
0,532  0,030  CYP2C9 substrate
0,502  0,005  Antiparkinsonian, rigidity relieving
0,501  0,005  UGT2B1 substrate
0,492  0,003  Glutamate dehydrogenase inhibitor
0,490  0,005  FMO3 substrate
0,525  0,043  Antidiabetic
0,525  0,043  Cyclophilin D inhibitor
0,509  0,030  Atherosclerosis treatment
0,500  0,028  Vasodilator, peripheral
0,475  0,003  NADH dehydrogenase inhibitor
0,495  0,026  Antihypercholesterolemic
0,473  0,005  GST M1-1 substrate
0,471  0,005  Pneumotoxic
0,469  0,003  UDP-glucose 4-epimerase inhibitor
0,508  0,044  TNF expression inhibitor
0,475  0,015  UGT2B4 substrate
0,462  0,003  Histidine decarboxylase inhibitor
0,479  0,024  Antipsoriatic
0,457  0,005  Gout treatment
0,483  0,030  5 Hydroxytryptamine release stimulant
0,451  0,009  Carcinogenic, group 3
0,450  0,010  Flavin-containing monooxygenase substrate
0,464  0,027  Radioprotector
0,451  0,016  Antihypertriglyceridemic
0,447  0,015  Antihypoxic
0,458  0,027  Analeptic
0,431  0,003  Phenylalanine 4-hydroxylase inhibitor
0,440  0,012  Anesthetic general
0,429  0,003  NAT1 substrate
0,436  0,012  UGT1A4 substrate
0,426  0,002  Biliverdin reductase inhibitor
0,423  0,004  Cystathionine beta-synthase inhibitor
0,421  0,003  GABA aminotransferase inhibitor
0,419  0,005  Aldehyde dehydrogenase inhibitor
0,429  0,016  Calcium channel activator
0,418  0,006  Tyrosine 3 hydroxylase inhibitor
0,414  0,003  Purinergic P2Y14 antagonist
0,423  0,013  Abortion inducer
0,413  0,003  Creatine kinase inhibitor
0,425  0,015  Interleukin agonist
0,434  0,025  Antidiabetic (type 2)
0,417  0,008  Protein-tyrosine phosphatase inhibitor
0,426  0,018  UDP-glucuronosyltransferase substrate
0,435  0,028  Cytostatic
0,405  0,003  Electrolyte absorption antagonist
0,409  0,008  GST P1-1 substrate
0,438  0,039  Teratogen
0,431  0,035  Hepatic disorders treatment
0,413  0,020  Sigma receptor agonist
0,408  0,016  UGT1A1 substrate
0,395  0,003  NAT2 substrate
0,430  0,042  Antithrombotic
0,390  0,003  Adenylate kinase inhibitor
0,397  0,011  Phospholipase C inhibitor
0,411  0,025  Radiosensitizer
0,462  0,077  Caspase 9 stimulant
0,423  0,039  Embryotoxic
0,404  0,021  DNA synthesis inhibitor
0,393  0,011  Genotoxic
0,397  0,015  Dual specificity phosphatase inhibitor
0,388  0,007  Antiparkinsonian, tremor relieving
0,414  0,035  ICAM1 expression inhibitor
0,385  0,006  Antihyperlipoproteinemic
0,395  0,018  Sodium/bile acid cotransporter inhibitor
0,400  0,026  Cardiodepressant
0,378  0,004  Carbonic anhydrase XV inhibitor
0,389  0,015  Dual specificity phosphatase 3 inhibitor
0,435  0,062  Antibacterial
0,408  0,037  Lipoprotein disorders treatment
0,382  0,013  Antiacne
0,379  0,012  Antipruritic, non-allergic
0,368  0,003  Keratolytic
0,369  0,004  Uric acid excretion stimulant
0,368  0,004  Antispirochetal
0,377  0,013  Mcl-1 antagonist
0,392  0,029  Hypoglycemic
0,367  0,004  Alcohol dehydrogenase inhibitor
0,398  0,036  Vasodilator, coronary
0,386  0,024  Insulysin inhibitor
0,401  0,040  AR expression inhibitor
0,362  0,006  Carcinogenic, group 1
0,363  0,011  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,361  0,008  Gastrin inhibitor
0,364  0,013  VCAM1 expression inhibitor
0,355  0,004  Prostaglandin E2 antagonist
0,356  0,013  Lipocortins synthesis antagonist
0,362  0,022  Eye irritation, high
0,345  0,007  Hexokinase inhibitor
0,351  0,020  Skin irritative effect
0,333  0,004  Arylamine N-Acetyltransferase substrate
0,332  0,004  GABA C receptor antagonist
0,334  0,007  UGT2B9 substrate
0,367  0,040  Chemoprotective
0,413  0,087  Antiarthritic
0,345  0,020  Antiviral (Influenza)
0,372  0,047  NOS3 expression inhibitor
0,349  0,024  RNA-directed DNA polymerase inhibitor
0,361  0,036  Carcinogenic
0,367  0,046  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,332  0,014  Muscular dystrophy treatment
0,335  0,017  UGT1A3 substrate
0,322  0,005  Carbonic anhydrase III inhibitor
0,337  0,020  UGT2B7 substrate
0,343  0,027  Cyclic AMP phosphodiesterase inhibitor
0,320  0,005  Mannose-6-phosphate isomerase inhibitor
0,319  0,004  Argininosuccinate synthase inhibitor
0,348  0,034  Acute neurologic disorders treatment
0,350  0,036  Mutagenic
0,322  0,009  Protein-tyrosine phosphatase 1B inhibitor
0,379  0,068  Transcription factor NF kappa B inhibitor
0,318  0,008  Aldehyde oxidase substrate
0,325  0,019  DNA methyltransferase I inhibitor
0,312  0,009  3C-like protease (Human coronavirus) inhibitor
0,341  0,038  Antidiabetic symptomatic
0,312  0,011  Renal failure treatment
0,351  0,050  CYP2C19 substrate
0,304  0,003  GABA C receptor rho-1 antagonist
0,369  0,069  Stroke treatment
0,316  0,016  Amylase inhibitor
0,323  0,024  Antihypotensive
0,316  0,017  Prostate disorders treatment
0,336  0,038  Transcription factor STAT3 inhibitor
0,355  0,058  Antihypertensive
0,301  0,005  Antithrombocytopenic
0,335  0,040  Transcription factor STAT inhibitor
0,297  0,002  Antidote, mercury
0,333  0,039  Pyruvate kinase inhibitor
0,296  0,003  Antirickettsial
0,314  0,024  DNA methylase inhibitor
0,299  0,009  SULT1A3 substrate
0,334  0,047  NOS2 expression inhibitor
0,292  0,004  Raynaud's phenomenon treatment
0,326  0,040  Vascular (periferal) disease treatment
0,300  0,015  Antidote
0,290  0,006  Phosphofructokinase-1 inhibitor
0,342  0,060  Apoptosis antagonist
0,324  0,042  Hypolipemic
0,299  0,017  UGT2B15 substrate
0,285  0,005  Prostaglandin antagonist
0,285  0,005  Potassium channel (Ca-activated) activator
0,293  0,014  Antidiabetic (type 1)
0,292  0,015  Phospholipase A2 inhibitor
0,303  0,027  Non-steroidal antiinflammatory agent
0,282  0,007  GABA C receptor rho-2 antagonist
0,295  0,021  Interferon gamma antagonist
0,280  0,007  Carbonic anhydrase VI inhibitor
0,282  0,010  Antianemic
0,349  0,078  CYP3A4 substrate
0,406  0,136  Antiinflammatory
0,277  0,007  Catalase inhibitor
0,275  0,005  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,278  0,008  Antieczematic
0,288  0,020  NOS3 expression enhancer
0,342  0,075  Inflammatory Bowel disease treatment
0,276  0,010  Aminopeptidase B inhibitor
0,265  0,003  GST T1-1 substrate
0,322  0,060  Interleukin 2 agonist
0,286  0,025  Diuretic
0,321  0,062  Spasmolytic
0,262  0,003  Nicotinic acid receptor 2 agonist
0,295  0,036  Wound healing agent
0,270  0,013  Cell wall synthesis inhibitor
0,273  0,016  M17 leucyl aminopeptidase inhibitor
0,278  0,022  Insulin sensitizer
0,261  0,004  HIV-1 integrase (Overall Integration) inhibitor
0,269  0,015  Cholesterol synthesis inhibitor
0,255  0,002  Retinoic acid beta receptor agonist
0,303  0,052  Platelet antagonist
0,313  0,063  CYP1A2 substrate
0,271  0,021  Nitric-oxide synthase stimulant
0,260  0,011  Xanthine oxidase inhibitor
0,266  0,017  Insulin secretagoues
0,252  0,003  Glutamate (mGluR3) antagonist
0,251  0,003  Acyl-CoA dehydrogenase inhibitor
0,254  0,008  Choleretic
0,298  0,053  Proliferative diseases treatment
0,254  0,008  Antineoplastic, alkylator
0,249  0,004  DOPA decarboxylase inhibitor
0,310  0,066  Cardioprotectant
0,269  0,026  Amyloid beta precursor protein antagonist
0,247  0,005  Prostaglandin EP2 antagonist
0,243  0,005  Potassium channel large-conductance Ca-activated activator
0,249  0,011  Catenin beta inhibitor
0,251  0,013  UGT2B10 substrate
0,263  0,025  Diabetic nephropathy treatment
0,240  0,002  Retinoic acid alpha receptor agonist
0,250  0,013  Expectorant
0,240  0,003  Fumarate hydratase inhibitor
0,282  0,045  Chemopreventive
0,238  0,002  Glutamate (mGluR6) antagonist
0,240  0,009  Carbonic anhydrase XIII inhibitor
0,240  0,010  Cyclooxygenase 3 inhibitor
0,237  0,008  Mucolytic
0,232  0,003  Antifungal (Pneumocystis)
0,235  0,006  Actinic keratosis treatment
0,253  0,025  CNS active muscle relaxant
0,284  0,056  Myocardial infarction treatment
0,327  0,099  Immunosuppressant
0,231  0,002  Retinoid X beta receptor agonist
0,252  0,024  Monophenol monooxygenase inhibitor
0,236  0,009  Movement disorders treatment
0,229  0,002  Ca2+-transporting ATPase inhibitor
0,254  0,028  Hair growth stimulant
0,231  0,005  Sphingosine 1-phosphate receptor 5 antagonist
0,256  0,030  Antiviral (West Nile virus)
0,230  0,005  Aminopeptidase I inhibitor
0,259  0,034  Neurotrophic factor enhancer
0,245  0,021  Antidiarrheal
0,246  0,022  NADPH oxidase inhibitor
0,288  0,064  Renal disease treatment
0,252  0,029  Cytidine deaminase inhibitor
0,229  0,006  Carcinogenic, group 2A
0,291  0,070  Hypoxia-inducible factor 1 alpha inhibitor
0,232  0,011  Arachidonic acid antagonist
0,228  0,007  Antiviral (Influenza B)
0,227  0,007  TRPA1 agonist
0,232  0,012  SULT1A1 substrate
0,248  0,029  Skeletal muscle relaxant
0,320  0,102  CYP2C9 inhibitor
0,254  0,036  I kappa B kinase epsilon inhibitor
0,220  0,003  NMDA 2D receptor antagonist
0,249  0,032  Antihelmintic (Nematodes)
0,243  0,027  Antiviral (Influenza A)
0,221  0,005  Heat shock protein 70 antagonist
0,236  0,020  VEGF expression inhibitor
0,225  0,009  Antiprotozoal (Babesia)
0,274  0,059  Free radical scavenger
0,262  0,047  Fibrosis treatment
0,230  0,016  Carcinogenic, group 2B
0,296  0,082  12-Lipoxygenase inhibitor
0,218  0,004  NMDA receptor agonist
0,219  0,006  Ornithine carbamoyltransferase inhibitor
0,217  0,004  Neuraminidase (influenza) inhibitor
0,220  0,008  ABCA1 expression enhancer
0,240  0,029  Protein kinase stimulant
0,230  0,019  Phobic disorders treatment
0,242  0,032  Urolithiasis treatment
0,214  0,004  Ornithine decarboxylase inhibitor
0,218  0,009  Antihelmintic (Fasciola)
0,226  0,017  Cathepsin H inhibitor
0,324  0,115  15-Lipoxygenase inhibitor
0,210  0,003  Purinergic P2X1 antagonist
0,211  0,004  CD45 antagonist
0,228  0,021  Glutathione S-transferase substrate
0,208  0,003  Nicotinic acid receptor agonist
0,220  0,015  Protein kinase (CK2) inhibitor
0,241  0,036  Antianorexic
0,207  0,003  Retinoic acid receptor agonist
0,208  0,004  Glycine receptor agonist
0,236  0,032  Histone acetyltransferase inhibitor
0,233  0,030  Cystic fibrosis treatment
0,239  0,036  Antiviral (Hepatitis)
0,309  0,108  Calpain 2 inhibitor
0,205  0,004  Plasminogen activator inhibitor antagonist
0,222  0,023  ATPase inhibitor
0,232  0,033  Age-related macular degeneration treatment
0,216  0,018  Farnesoid X receptor antagonist
0,237  0,039  Prostatic (benign) hyperplasia treatment
0,209  0,011  Photosensitizer
0,217  0,021  Protein kinase (CK2) alpha inhibitor
0,201  0,008  Macrophage migration inhibitory factor inhibitor
0,252  0,059  Antiulcerative
0,282  0,090  CYP2D6 substrate
0,276  0,084  Lipoxygenase inhibitor
0,204  0,012  Aldehyde dehydrogenase substrate
0,195  0,003  D-Ala-D-Ala ligase inhibitor
0,200  0,009  Sphingosine 1-phosphate receptor 4 antagonist
0,309  0,118  CYP2C19 inhibitor
0,264  0,073  Aryl hydrocarbon receptor agonist
0,198  0,008  Sphingosine 1-phosphate receptor 2 antagonist
0,213  0,024  DNA polymerase I inhibitor
0,203  0,013  Protein kinase C gamma inhibitor
0,220  0,032  Antiviral (Hepatitis C)
0,189  0,001  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,264  0,077  Antioxidant
0,274  0,087  Immunostimulant
0,207  0,021  Toll-Like receptor 2 antagonist
0,190  0,004  Neuraminidase inhibitor
0,213  0,028  Hemostatic
0,202  0,018  Antischistosomal
0,188  0,004  Prostaglandin EP1 antagonist
0,195  0,012  AMP-activated protein kinase stimulant
0,198  0,015  Mediator release inhibitor
0,188  0,005  Xanthine dehydrogenase inhibitor
0,220  0,038  LDLR expression enhancer
0,191  0,010  HIV-1 integrase (3'-Processing) inhibitor
0,222  0,042  Thrombolytic
0,183  0,004  Antiviral (Parainfluenza)
0,215  0,036  Anesthetic
0,182  0,004  Hyperparathyroidism treatment
0,181  0,003  Glutamate (mGluR4) antagonist
0,200  0,022  Antineoplastic antimetabolite
0,248  0,071  Angiogenesis stimulant
0,200  0,024  Chelator
0,179  0,003  Dihydroorotase inhibitor
0,207  0,031  Neurotensin receptor agonist
0,215  0,041  5 Hydroxytryptamine 3E antagonist
0,210  0,037  Melanin inhibitor
0,199  0,026  Adenylate cyclase inhibitor
0,185  0,011  NAD(P)H dehydrogenase (quinone) inhibitor
0,178  0,005  Antidote, heavy metal
0,176  0,003  Glutamate (mGluR group III) antagonist
0,235  0,062  Peptidyltransferase inhibitor
0,231  0,059  Antialcoholic
0,176  0,005  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,202  0,032  Anesthetic local
0,194  0,024  Interleukin 4 antagonist
0,180  0,011  HIV-1 integrase (Strand Transfer) inhibitor
0,222  0,053  Hepatoprotectant
0,201  0,032  Aldose reductase substrate
0,173  0,004  Anticholelithogenic
0,189  0,022  Microtubule formation inhibitor
0,173  0,007  Carbonic anhydrase VB inhibitor
0,181  0,016  HDL-cholesterol increasing
0,186  0,022  Adenylate cyclase stimulant
0,200  0,037  Uterine stimulant
0,175  0,013  Glutamate receptor agonist
0,190  0,028  Antitussive
0,183  0,021  Coagulant
0,171  0,010  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,227  0,067  Psychostimulant
0,193  0,033  Cocaine dependence treatment
0,233  0,073  Neuropeptide Y2 antagonist
0,230  0,070  Antiparasitic
0,163  0,003  Adenine nucleotide translocase inhibitor
0,237  0,077  Antiamyloidogenic
0,169  0,009  Carbamoyl phosphate synthetase inhibitor
0,210  0,051  Muscle relaxant
0,163  0,004  GABA B receptor agonist
0,162  0,004  TRPM8 blocker
0,165  0,007  Glutamate release inhibitor
0,168  0,011  Carbonic anhydrase V inhibitor
0,171  0,015  Prolactin inhibitor
0,190  0,036  Antifungal enhancer
0,159  0,004  NMDA receptor glycine site agonist
0,191  0,036  M18 aspartyl aminopeptidase inhibitor
0,161  0,007  Autotaxin inhibitor
0,217  0,063  Osteoarthritis treatment
0,195  0,041  Thiol protease inhibitor
0,172  0,019  NMDA receptor antagonist
0,185  0,032  CF transmembrane conductance regulator agonist
0,155  0,003  Retinoid X alpha receptor agonist
0,156  0,004  Kainate receptor antagonist
0,178  0,027  Antihelmintic (Trematoda)
0,155  0,005  Granulocyte macrophage colony stimulating factor agonist
0,161  0,011  Paget's disease treatment
0,210  0,060  CYP2B6 inhibitor
0,162  0,013  Anabolic
0,187  0,039  Antiprotozoal (Coccidial)
0,159  0,011  Histamine N-methyltransferase inhibitor
0,174  0,027  Falcipain 3 inhibitor
0,149  0,002  Retinoid X gamma receptor agonist
0,178  0,032  Cell adhesion inhibitor
0,173  0,027  Growth stimulant
0,249  0,103  Streptokinase A inhibitor
0,185  0,039  Alkaline phosphatase inhibitor
0,174  0,028  Antiviral (Poxvirus)
0,159  0,013  CC chemokine 6 receptor antagonist
0,151  0,007  Bile acid receptor antagonist
0,215  0,072  Cytotoxic
0,163  0,020  Caspase 3 inhibitor
0,302  0,160  DNA directed DNA polymerase inhibitor
0,144  0,003  Antidote, organophosphates
0,151  0,011  Carbonic anhydrase VA inhibitor
0,303  0,164  DNA polymerase beta inhibitor
0,146  0,006  NMDA receptor subunit 3B antagonist
0,227  0,088  Calpain inhibitor
0,139  0,001  Vesicular glutamate transport inhibitor
0,142  0,003  Antihemophilic
0,160  0,021  Chronic obstructive bronchitis treatment
0,152  0,014  UGT2B11 substrate
0,146  0,008  Glycine receptor antagonist
0,138  0,002  Retinoic acid beta receptor antagonist
0,138  0,003  Dihydroorotate oxidase inhibitor
0,148  0,013  Peroxisome proliferator-activated receptor gamma agonist
0,138  0,005  Prostaglandin F2 alpha antagonist
0,173  0,040  Topoisomerase II inhibitor
0,160  0,028  Interleukin 8 antagonist
0,137  0,005  Dihydroorotate dehydrogenase inhibitor
0,145  0,013  Glutathione S-transferase inhibitor
0,226  0,095  DNA damaging
0,151  0,021  Cathepsin G inhibitor
0,152  0,022  Urease inhibitor
0,132  0,002  Sodium-dependent vitamin C transporter 2 inhibitor
0,132  0,004  Glutamate (mGluR7) antagonist
0,215  0,087  Antiglaucomic
0,131  0,003  Retinoid X receptor agonist
0,218  0,091  Vasodilator
0,186  0,059  Antipruritic
0,196  0,069  Antihelmintic
0,153  0,027  Sulfotransferase substrate
0,157  0,031  Gastritis treatment
0,150  0,025  Beta glucuronidase inhibitor
0,170  0,044  Neurotrophic factor
0,155  0,030  Contraceptive female
0,173  0,048  Pancreatic disorders treatment
0,130  0,006  Glutamate (mGluR group III) agonist
0,165  0,041  Glutamate receptor antagonist
0,125  0,002  Retinoic acid receptor gamma antagonist
0,128  0,005  Leukotriene A4 hydrolase inhibitor
0,156  0,034  Menstruation disorders treatment
0,162  0,040  Antiprotozoal (Trichomonas)
0,123  0,002  Retinoic acid alpha receptor antagonist
0,159  0,038  Antiprotozoal (Amoeba)
0,127  0,007  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,123  0,003  GABA uptake inhibitor
0,129  0,009  Phosphorylase inhibitor
0,143  0,024  Antiprotozoal (Toxoplasma)
0,137  0,018  Glutamate (mGluR7) agonist
0,162  0,043  MAP kinase kinase 4 inhibitor
0,128  0,009  CDC25B inhibitor
0,150  0,031  Anticataract
0,120  0,002  Glutamate (mGluR8) agonist
0,136  0,018  Lanosterol 14 alpha demethylase inhibitor
0,128  0,010  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,133  0,016  Antifungal (Aspergillus)
0,149  0,032  DNA repair enzyme inhibitor
0,133  0,016  Interleukin 5 antagonist
0,121  0,004  Neuraminidase (Influenza A) inhibitor
0,124  0,009  Estrogen-related receptor beta agonist
0,174  0,059  Neuropathy treatment
0,129  0,014  Leukotriene antagonist
0,118  0,003  Kynurenine 3 monooxygenase inhibitor
0,120  0,006  Nicotinic acid receptor 1 agonist
0,117  0,002  Retinoic acid receptor antagonist
0,134  0,019  Tourette's syndrome treatment
0,134  0,019  Antiviral (Rhinovirus)
0,244  0,130  Prostaglandin dehydrogenase inhibitor
0,283  0,169  Alpha-glucosidase inhibitor
0,124  0,011  Protein kinase C eta inhibitor
0,120  0,007  NMDA receptor subunit 3A antagonist
0,167  0,055  Pulmonary hypertension treatment
0,190  0,079  Antiviral (Ebola)
0,116  0,005  SULT2A1 substrate
0,119  0,007  Phospholipase D inhibitor
0,121  0,010  Maillard reaction inhibitor
0,132  0,021  NMDA 2 receptor antagonist
0,114  0,003  Glutamate (mGluR1) agonist
0,231  0,121  Metabolic disease treatment
0,118  0,008  5-Alpha-reductase inhibitor
0,175  0,066  Heat shock protein 90 alpha antagonist
0,120  0,010  NMDA 2C receptor antagonist
0,114  0,005  Urate transporter 1 inhibitor
0,116  0,007  Topoisomerase II beta inhibitor
0,147  0,039  5-Lipoxygenase inhibitor
0,145  0,037  Alcohol dehydrogenase substrate
0,122  0,014  HIV-1 integrase inhibitor
0,148  0,041  Vanilloid 1 agonist
0,115  0,008  Carbonic anhydrase XIV inhibitor
0,109  0,004  Glutamate (mGluR1a) agonist
0,110  0,005  Mannosidase inhibitor
0,109  0,004  Dihydropteroate synthase inhibitor
0,111  0,006  MAP kinase kinase 7 inhibitor
0,152  0,048  Retinoprotector
0,109  0,005  MDM2 inhibitor
0,143  0,040  Antiviral (Papilloma)
0,120  0,017  Leukotriene synthesis inhibitor
0,133  0,030  Acetylcholine release stimulant
0,105  0,002  Retinoic acid gamma receptor agonist
0,216  0,113  5 Hydroxytryptamine 1E antagonist
0,110  0,007  Potassium channel intermediate-conductance Ca-activated blocker
0,107  0,005  RNA-directed RNA polymerase inhibitor
0,107  0,004  Lysophosphatidic acid 3 receptor antagonist
0,107  0,005  AMPA 4 receptor antagonist
0,107  0,005  Carnitine palmitoyltransferase 1B inhibitor
0,111  0,009  Antimycoplasmal
0,173  0,072  Liver fibrosis treatment
0,118  0,017  Sphingosine 1-phosphate receptor 4 agonist
0,105  0,004  Glucose-6-phosphate isomerase inhibitor
0,105  0,005  5-Alpha-reductase 2 inhibitor
0,130  0,030  Calcium antagonist
0,114  0,014  DNA gyrase inhibitor
0,111  0,011  Peroxisome proliferator-activated receptor gamma antagonist
0,124  0,024  Antiviral (Trachoma)
0,130  0,030  Factor V inhibitor
0,152  0,053  Skin whitener
0,147  0,048  Antibacterial (Helicobacter pylori)
0,147  0,048  Antiviral (Hepatitis B)
0,102  0,004  Prostaglandin EP4 agonist
0,108  0,010  Protein kinase C beta inhibitor
0,101  0,005  Factor III inhibitor
0,107  0,010  AMPA receptor antagonist
0,194  0,099  Antiviral (HIV)
0,099  0,004  Pregnane X receptor antagonist
0,145  0,049  Alkylator
0,126  0,030  Interleukin 1 beta converting enzyme inhibitor
0,105  0,010  S-adenosyl-L-methionine decarboxylase inhibitor
0,105  0,010  Thromboxane antagonist
0,100  0,005  Kainate receptor 2 antagonist
0,134  0,039  Transcription factor STAT6 inhibitor
0,101  0,006  Thromboxane synthase inhibitor
0,098  0,004  Prostaglandin EP4 antagonist
0,096  0,002  Nicotinic acid receptor 2 antagonist
0,280  0,187  Apoptosis agonist
0,111  0,017  Narcotic antagonist
0,098  0,004  Farnesoid X receptor agonist
0,097  0,004  Kainate receptor 1 antagonist
0,102  0,010  Leukotriene B4 antagonist
0,117  0,025  Cell adhesion molecule inhibitor
0,135  0,043  Shock treatment
0,113  0,021  Prostaglandin-E synthase inhibitor
0,127  0,036  Sphingomyelinase inhibitor
0,097  0,006  Guanylate cyclase stimulant
0,117  0,027  Transcription factor NF kappa B stimulant
0,094  0,004  Methionyl aminopeptidase 2 inhibitor
0,183  0,093  MAP kinase kinase 2 inhibitor
0,113  0,024  Selectin antagonist
0,117  0,027  Adrenaline agonist
0,093  0,003  Nerve growth factor antagonist
0,168  0,078  Toxic, respiratory center
0,092  0,003  Kainate receptor agonist
0,195  0,106  Urologic disorders treatment
0,092  0,002  Glutamate (mGluR3) agonist
0,117  0,028  Phosphodiesterase 6D inhibitor
0,097  0,009  Sphingosine 1-phosphate receptor 3 antagonist
0,094  0,006  Anesthetic inhalation
0,121  0,034  MAP kinase kinase 1 inhibitor
0,095  0,007  Alpha-mannosidase inhibitor
0,100  0,013  NMDA 2A receptor antagonist
0,091  0,005  HCV NS5B polymerase inhibitor
0,090  0,005  Ryanodine receptor antagonist
0,110  0,025  3C-Like protease (SARS coronavirus) inhibitor
0,141  0,056  Antihemorrhagic
0,094  0,009  Thromboxane A2 antagonist
0,089  0,005  Heparanase inhibitor
0,092  0,008  Glutamate (mGluR group II) agonist
0,097  0,013  Peroxisome proliferator-activated receptor alpha agonist
0,089  0,006  Prostaglandin agonist
0,088  0,005  Leukotriene C antagonist
0,086  0,005  5-Alpha-reductase 1 inhibitor
0,102  0,020  Sphingosine 1-phosphate receptor antagonist
0,129  0,048  Endometrios treatment
0,085  0,004  Protein kinase (CK2) beta inhibitor
0,194  0,113  Antineoplastic (liver cancer)
0,105  0,025  CDC25A inhibitor
0,088  0,008  DNA helicase inhibitor
0,119  0,040  Folate antagonist
0,121  0,042  Mental retardation treatment
0,104  0,025  Interferon agonist
0,085  0,006  AICAR transformylase inhibitor
0,089  0,010  Diacylglycerol O-acyltransferase inhibitor
0,082  0,003  Retinoid X receptor antagonist
0,082  0,004  Kainate receptor 5 antagonist
0,108  0,031  Antileprosy
0,085  0,008  Adenosine deaminase inhibitor
0,091  0,014  Exportin-1 inhibitor
0,109  0,033  Restless leg syndrome treatment
0,105  0,029  Myeloperoxidase inhibitor
0,107  0,031  Antibiotic
0,078  0,003  Guanylate cyclase inhibitor
0,146  0,071  Neuropeptide Y1 antagonist
0,078  0,004  Uridine phosphorylase inhibitor
0,136  0,062  Liver cirrhosis treatment
0,129  0,055  Interleukin 1b antagonist
0,082  0,008  Factor XIa inhibitor
0,202  0,129  Antineurogenic pain
0,105  0,031  Hematopoietic
0,087  0,014  Factor IXa inhibitor
0,148  0,076  Acetylcholine M1 receptor antagonist
0,081  0,008  Glutamate (mGluR2) agonist
0,081  0,009  Squalene epoxidase inhibitor
0,079  0,007  AMPA 1 receptor antagonist
0,146  0,074  MAP kinase 3 inhibitor
0,078  0,006  Arginase inhibitor
0,092  0,021  Antiemphysemic
0,075  0,004  Glutamate (mGluR8) antagonist
0,117  0,046  Gastric antisecretory
0,076  0,005  Geranyltranstransferase inhibitor
0,159  0,089  Tumour necrosis factor antagonist
0,096  0,026  Calcium channel L-type blocker
0,076  0,006  Dopamine beta hydroxylase inhibitor
0,136  0,066  Cyclooxygenase 1 inhibitor
0,082  0,012  Purinergic P2Y antagonist
0,113  0,044  Antihypermotility
0,077  0,008  Somatostatin 5 antagonist
0,101  0,033  Antiprotozoal activity enhancer
0,071  0,003  Retinoid X alpha receptor antagonist
0,074  0,006  Membrane dipeptidase inhibitor
0,161  0,094  Platelet adhesion inhibitor
0,119  0,053  Myasthenia Gravis treatment
0,140  0,074  Pregnane X receptor agonist
0,091  0,025  Vanilloid 4 agonist
0,090  0,025  Antitreponemal
0,085  0,020  Interferon inducer
0,098  0,033  Na+ K+ transporting ATPase inhibitor
0,078  0,013  Sphingosine 1-phosphate receptor 5 agonist
0,072  0,008  Dopamine D5 agonist
0,068  0,004  Calcium-sensing receptor agonist
0,094  0,030  SULT1A2 substrate
0,073  0,009  Immunoglobulin Fc receptor antagonist
0,136  0,072  Nav1.6 sodium channel blocker
0,067  0,004  Angiotensin II receptor antagonist
0,067  0,004  GABA transporter 3 inhibitor
0,071  0,008  GABA B receptor antagonist
0,066  0,004  Angiotensin AT1 receptor antagonist
0,067  0,005  Free fatty acid receptor 1 antagonist
0,064  0,002  Retinoid X beta receptor antagonist
0,071  0,009  Phosphoglycerate kinase inhibitor
0,088  0,027  Glutamate (mGluR) agonist
0,066  0,005  Leukotriene B4 receptor 1 antagonist
0,075  0,014  Carbonic anhydrase VII inhibitor
0,085  0,025  Endocannabinoid uptake inhibitor
0,067  0,007  Glutamate (mGluR4) agonist
0,064  0,004  Prostaglandin EP2 agonist
0,137  0,078  Lipid peroxidase inhibitor
0,082  0,023  Glutamate (mGluR1) antagonist
0,063  0,005  Carnitine palmitoyltransferase inhibitor
0,083  0,025  Protease 3C (Human rhinovirus) inhibitor
0,065  0,007  Peroxisome proliferator-activated receptor delta antagonist
0,063  0,005  Prostaglandin E2 agonist
0,089  0,031  Carbonic anhydrase inhibitor
0,074  0,016  Myc inhibitor
0,063  0,005  Leukotriene C4 antagonist
0,062  0,005  LFA antagonist
0,062  0,005  AMPA 3 receptor antagonist
0,062  0,005  NMDA receptor glycine site antagonist
0,071  0,014  Leukocyte elastase inhibitor
0,061  0,005  Carnitine palmitoyltransferase 1 inhibitor
0,099  0,042  Bromodomain-containing protein 2 inhibitor
0,112  0,055  Antiinfertility, female
0,069  0,013  Fructose-1,6-bisphosphatase inhibitor
0,063  0,006  Integrin alpha2 antagonist
0,061  0,005  ATP citrate lysase inhibitor
0,075  0,020  Calcium channel P-type blocker
0,075  0,019  Heme oxygenase stimulant
0,131  0,076  Bone formation stimulant
0,068  0,013  Thymidylate synthase inhibitor
0,067  0,013  Sphingosine 1-phosphate receptor agonist
0,158  0,105  P-glycoprotein inhibitor
0,088  0,034  Epoxide hydrolase inhibitor
0,149  0,096  Nitric oxide antagonist
0,097  0,043  Tocolytic
0,094  0,041  mTOR complex 2 inhibitor
0,059  0,006  Liver X receptor beta antagonist
0,066  0,013  Glutamate (mGluR1a) antagonist
0,057  0,004  Tryptophan 5 hydroxylase inhibitor
0,163  0,110  Focal adhesion kinase 2 inhibitor
0,056  0,004  Lysophosphatidic acid 1 receptor antagonist
0,067  0,015  Aldosterone antagonist
0,070  0,018  Sphingosine 1-phosphate receptor 1 antagonist
0,106  0,053  Antifibrinolytic
0,057  0,005  CF transmembrane conductance regulator antagonist
0,066  0,014  Adenylate cyclase 1 inhibitor
0,153  0,102  Sedative
0,077  0,026  Carbonic anhydrase I inhibitor
0,053  0,003  Nicotinic acid receptor 1 antagonist
0,122  0,072  Nav1.3 sodium channel blocker
0,053  0,003  Retinoid X gamma receptor antagonist
0,077  0,027  Collagenase 3 inhibitor
0,113  0,062  5 Hydroxytryptamine 3A agonist
0,067  0,017  Glucose-6-phosphate translocase inhibitor
0,074  0,024  Phosphodiesterase 1C inhibitor
0,057  0,007  Lysophosphatidic acid 2 receptor antagonist
0,073  0,023  Fatty acid synthase inhibitor
0,053  0,004  Prostaglandin H2 antagonist
0,053  0,004  Antibiotic Naphthyridine-like
0,090  0,041  Thioredoxin reductase inhibitor
0,075  0,027  Beta 3 adrenoreceptor antagonist
0,066  0,018  Prolyl endopeptidase inhibitor
0,059  0,011  Glutamate (mGluR group II) antagonist
0,052  0,004  Calcium-independent phospholipase A2 inhibitor
0,089  0,042  CYP2A6 inhibitor
0,050  0,003  Vanilloid 2 agonist
0,050  0,003  Carbonic anhydrase X inhibitor
0,050  0,003  Carbonic anhydrase VIII inhibitor
0,099  0,052  Protein kinase C zeta inhibitor
0,055  0,008  GABA transporter 2 inhibitor
0,049  0,002  Neuraminidase (Influenza B) inhibitor
0,050  0,003  GABA transporter inhibitor
0,106  0,060  Toll-Like receptor 4 antagonist
0,074  0,029  Carbonic anhydrase stimulant
0,066  0,021  Nicotinic alpha3beta2 receptor antagonist
0,073  0,028  Carbonic anhydrase XII inhibitor
0,073  0,028  Androgen agonist
0,063  0,018  Carbonic anhydrase IV inhibitor
0,049  0,005  Protocollagen prolyl hydroxylase inhibitor
0,175  0,131  Heart failure treatment
0,052  0,008  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,050  0,006  Methionyl aminopeptidase 1 inhibitor
0,058  0,014  Liver X receptor alpha agonist
0,049  0,006  Epoxide hydrolase 1 inhibitor
0,070  0,027  Aldose reductase inhibitor
0,056  0,013  DNA gyrase subunit A inhibitor
0,088  0,045  Caspase 7 inhibitor
0,075  0,032  Uterine relaxant
0,047  0,005  Integrin alpha2beta1 antagonist
0,052  0,010  AMPA 2 receptor antagonist
0,051  0,010  Factor XI inhibitor
0,046  0,005  Leukotriene B4 receptor 2 antagonist
0,049  0,008  Peroxisome proliferator-activated receptor alpha antagonist
0,117  0,076  MAP kinase kinase inhibitor
0,067  0,026  Beta 2 adrenoreceptor agonist
0,143  0,103  Hearing loss treatment
0,053  0,013  Diamine oxidase inhibitor
0,048  0,008  Carnitine palmitoyltransferase 1A inhibitor
0,045  0,005  Protease (Human cytomegalovirus) inhibitor
0,086  0,046  CC chemokine 5 receptor agonist
0,066  0,026  Postcoital contraceptive
0,057  0,017  Purinergic P2X4 antagonist
0,071  0,032  Carbonic anhydrase IX inhibitor
0,049  0,010  Angiotensin AT2 receptor antagonist
0,069  0,030  Carbonic anhydrase II inhibitor
0,106  0,067  Multidrug resistance-associated protein 1 inhibitor
0,041  0,002  Glutamate (mGluR6) agonist
0,190  0,151  Antiischemic
0,043  0,005  Lysophosphatidic acid receptor 1 agonist
0,060  0,022  Glutamate (mGluR group I) agonist
0,077  0,039  Bulimia treatment
0,043  0,006  Protein kinase C beta I inhibitor
0,052  0,015  Beta adrenoreceptor agonist
0,048  0,011  Purinergic P2Y2 antagonist
0,046  0,009  Cholesterol ester transfer protein antagonist
0,047  0,010  Leukotriene D4 antagonist
0,083  0,047  Nicotinic alpha4beta2 receptor antagonist
0,052  0,015  Alpha 1d adrenoreceptor agonist
0,053  0,017  Sphingosine 1-phosphate receptor 1 agonist
0,046  0,009  Prostaglandin D2 agonist
0,234  0,199  Transcription factor inhibitor
0,083  0,048  Somatostatin 1 agonist
0,043  0,009  Lysine carboxypeptidase inhibitor
0,037  0,003  Egl nine homolog 3 inhibitor
0,047  0,013  Cholesterol absorption inhibitor
0,056  0,023  Oleamide hydrolase inhibitor
0,038  0,004  Antibiotic Quinolone-like
0,061  0,028  Epithelial sodium channel blocker
0,037  0,004  Egl nine homolog 1 inhibitor
0,038  0,005  GRP78 expression inhibitor
0,130  0,098  Heat shock protein 90 antagonist
0,062  0,029  Sphingosine kinase 2 inhibitor
0,076  0,044  Potassium channel (Tandem pore domain) blocker
0,054  0,022  Phosphate transporter inhibitor
0,042  0,011  Hypoxanthine phosphoribosyltransferase inhibitor
0,055  0,023  Cholesterol esterase inhibitor
0,104  0,073  GABA receptor agonist
0,070  0,039  Beta adrenoreceptor antagonist
0,045  0,015  Prostacyclin antagonist
0,117  0,087  Nav1.2 sodium channel blocker
0,080  0,049  Estrogen receptor alpha antagonist
0,044  0,014  Vanilloid 3 antagonist
0,061  0,030  Glucosylceramidase inhibitor
0,037  0,007  Estrogen-related receptor gamma antagonist
0,185  0,155  Antiepileptic
0,066  0,037  Transcription factor RelA inhibitor
0,139  0,110  LIM domain kinase 1 inhibitor
0,115  0,086  Antismoking
0,044  0,015  Peroxisome proliferator-activated receptor delta agonist
0,030  0,001  Mannitol 2-dehydrogenase inhibitor
0,200  0,172  Thioredoxin glutathione reductase inhibitor
0,128  0,100  Antiviral (Herpes)
0,055  0,027  Bombesin 2 receptor antagonist
0,069  0,042  Andropause treatment
0,062  0,035  Sphingosine kinase inhibitor
0,039  0,012  Protein kinase C beta II inhibitor
0,081  0,053  Chymotrypsin inhibitor
0,153  0,126  Anticonvulsant
0,041  0,014  Liver X receptor beta agonist
0,030  0,003  GABA transporter 1 inhibitor
0,046  0,019  Heme oxygenase inhibitor
0,106  0,079  Proteasome inhibitor
0,086  0,059  Androgen antagonist
0,047  0,021  Thymidine kinase inhibitor
0,035  0,008  Excitatory amino acid transporter 2 inhibitor
0,038  0,012  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,058  0,032  Angiotensin-converting enzyme inhibitor
0,053  0,027  Antiviral (Herpesvirus 3, Human)
0,030  0,004  Angiotensin AT1B receptor antagonist
0,032  0,006  Complement factor 1s inhibitor
0,028  0,003  Methylmalonyl-CoA mutase inhibitor
0,094  0,069  Antifungal (Candida)
0,060  0,035  Beta 1 adrenoreceptor antagonist
0,047  0,022  Dihydrofolate reductase inhibitor
0,061  0,036  Botulinum neurotoxin type A inhibitor
0,083  0,058  Histamine H2 receptor antagonist
0,114  0,089  Glycogen synthase kinase-3 alpha inhibitor
0,043  0,019  DNA gyrase subunit B inhibitor
0,030  0,006  Aminopeptidase A inhibitor
0,052  0,029  HCV NS3/NS4A protease inhibitor
0,069  0,046  Gaucher disease treatment
0,116  0,094  Cytokine production inhibitor
0,026  0,004  Human herpes virus 5 capsid protein P40 inhibitor
0,030  0,009  Prostaglandin F2 alpha agonist
0,038  0,016  Melatonin receptor 1A agonist
0,029  0,007  ICAM 1 antagonist
0,034  0,012  Kainate receptor 4 antagonist
0,030  0,008  Beta 1 adrenoreceptor agonist
0,086  0,065  Aminoacyl-tRNA synthetase inhibitor
0,039  0,018  Squalene synthetase inhibitor
0,035  0,014  Glutamate (mGluR2) antagonist
0,081  0,060  Inducible nitric-oxide synthase inhibitor
0,028  0,008  Monocarboxylic acid transporter inhibitor
0,028  0,008  Monocarboxylic acid transporter 1 inhibitor
0,087  0,067  Thioredoxin inhibitor
0,033  0,013  Purinergic P2Y15 antagonist
0,046  0,027  Estradiol 17 beta-dehydrogenase inhibitor
0,190  0,171  Thyroid hormone antagonist
0,024  0,004  Lysophosphatidic acid receptor 3 agonist
0,085  0,066  Contraceptive male
0,027  0,008  Angiotensin AT1A receptor antagonist
0,086  0,067  Potassium channel activator
0,034  0,016  Diacylglycerol O-acyltransferase 1 inhibitor
0,071  0,053  Lipase inhibitor
0,022  0,004  Carbonic anhydrase XI inhibitor
0,022  0,004  Thrombopoietin agonist
0,036  0,018  Nucleoside transporters inhibitor
0,124  0,106  MAP3K9 inhibitor
0,025  0,007  Kainate receptor 3 antagonist
0,041  0,024  Glucagon-like peptide 1 receptor antagonist
0,023  0,005  CXC chemokine 5 receptor antagonist
0,059  0,042  Bcl-xL inhibitor
0,029  0,012  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,047  0,030  Glutamate (mGluR5) agonist
0,025  0,008  Excitatory amino acid transporter 3 inhibitor
0,027  0,010  Fructose-1,6-bisphosphatase 1 inhibitor
0,027  0,010  Bombesin agonist
0,030  0,013  Hedgehog signaling activator
0,035  0,019  Carboxypeptidase B inhibitor
0,026  0,009  Isoleucine-tRNA ligase inhibitor
0,032  0,016  Endothelin receptor antagonist
0,021  0,005  Thromboxane A2 agonist
0,063  0,047  Neutrophil collagenase inhibitor
0,084  0,069  Phosphodiesterase I inhibitor
0,114  0,099  Histone deacetylase SIRT1 inhibitor
0,028  0,014  Thymidine phosphorylase inhibitor
0,023  0,009  Bombesin 3 receptor agonist
0,021  0,007  Telomerase stimulant
0,050  0,036  Beta 2 adrenoreceptor antagonist
0,022  0,008  G-protein-coupled receptor 120 agonist
0,022  0,008  Antibiotic Anthracycline-like
0,102  0,089  Acetylcholine muscarinic antagonist
0,050  0,037  Potassium channel (Inward rectifier) activator
0,132  0,119  Diabetic retinopathy treatment
0,075  0,062  Histamine H1 receptor antagonist
0,017  0,004  Thromboxane agonist
0,023  0,011  Endothelin B receptor antagonist
0,042  0,030  Oxytocin agonist
0,058  0,046  Phosphodiesterase 1A inhibitor
0,032  0,020  Prostaglandin EP3 antagonist
0,047  0,035  Potassium channel (ATP-sensitive) activator
0,121  0,110  Anticoagulant
0,102  0,091  Calcium channel N-type blocker
0,027  0,016  Thyroid hormone agonist
0,028  0,017  CXC chemokine 2 receptor antagonist
0,112  0,101  Interleukin 1 antagonist
0,050  0,040  Ribonucleoside-diphosphate reductase inhibitor
0,020  0,010  Complement factor D inhibitor
0,052  0,042  CC chemokine 2 receptor antagonist
0,045  0,035  Antimetabolite
0,021  0,011  Caspase 8 inhibitor
0,015  0,006  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,030  0,021  Elastase 2B inhibitor
0,030  0,021  Elastase 3B inhibitor
0,030  0,021  Elastase 3A inhibitor
0,109  0,100  Calcium channel blocker
0,047  0,038  Cytokine production stimulant
0,051  0,042  Ribonucleotide reductase inhibitor
0,064  0,055  Elastase 1 inhibitor
0,033  0,025  HCV polyprotein inhibitor
0,029  0,020  Liver X receptor alpha antagonist
0,021  0,012  Vesicular acetylcholine transporter inhibitor
0,015  0,006  Integrin beta2 antagonist
0,068  0,059  Nav1.8 sodium channel blocker
0,012  0,004  Folate transporter 1 inhibitor
0,042  0,034  Histamine H1 receptor agonist
0,035  0,027  Ceramide glucosyltransferase inhibitor
0,021  0,013  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,019  0,012  Estrogen-related receptor gamma agonist
0,055  0,048  Heat shock protein 90 beta antagonist
0,045  0,038  Benzodiazepine antagonist
0,031  0,024  Dipeptidyl peptidase II inhibitor
0,177  0,170  Antifungal
0,187  0,180  Antiallergic
0,113  0,107  Antiischemic, cerebral
0,029  0,023  Liver X receptor antagonist
0,058  0,052  Trypsin inhibitor
0,030  0,024  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,025  0,020  Sodium/glucose cotransporter 2 inhibitor
0,098  0,092  Beta amyloid protein antagonist
0,037  0,032  Toll-Like receptor 2 agonist
0,057  0,051  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,057  0,051  Transcription factor AP-1 inhibitor
0,043  0,038  Potassium channel Kv1.3 blocker
0,068  0,062  Adenosine A3 receptor antagonist
0,019  0,014  Guanylate cyclase 1 stimulant
0,042  0,038  Microtubule stabilization
0,008  0,003  Insulin like growth factor 3 antagonist
0,055  0,050  Lipocortins synthesis agonist
0,033  0,029  AMPA receptor agonist
0,016  0,013  Ileal bile acid transport inhibitor
0,070  0,066  Metalloproteinase-2 inhibitor
0,008  0,005  DNA topoisomerase III inhibitor
0,082  0,079  Polo-like kinase-1 inhibitor
0,028  0,025  DNA topoisomerase IV inhibitor
0,012  0,009  Egl nine homolog 2 inhibitor
0,024  0,021  Sodium/glucose cotransporter inhibitor
0,014  0,011  N-Acetylated alpha-linked acidic dipeptidase inhibitor
0,059  0,057  Acetylcholine M5 receptor agonist
0,054  0,052  TRPA1 antagonist
0,019  0,017  Endothelin A receptor antagonist
0,020  0,018  Geranylgeranyltransferase inhibitor
0,006  0,005  Integrin alpha5beta6 antagonist
0,011  0,009  CD80 antagonist
0,016  0,014  CC chemokine 9 receptor antagonist
0,054  0,052  Phosphodiesterase 1B inhibitor
0,014  0,013  Purinergic P2Y1 agonist
0,004  0,003  Antibiotic Carbapenem-like
0,056  0,055  Nitric oxide donor
0,010  0,009  Beta 3 adrenoreceptor agonist
0,042  0,042  CC chemokine 4 receptor antagonist
0,122  0,122  Antifungal (Cryptococcus)
0,029  0,028  Calcitonin receptor agonist
0,056  0,056  5 Hydroxytryptamine 3 agonist
0,071  0,070  Xanthine oxidase substrate
0,016  0,016  Tryptophan hydroxylase 1 inhibitor
0,049  0,049  Matrix metalloproteinase (membrane-type) inhibitor

